2-175939622-T-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_030650.3(LNPK):āc.742A>Gā(p.Ile248Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0004 in 1,606,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_030650.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LNPK | NM_030650.3 | c.742A>G | p.Ile248Val | missense_variant | 10/13 | ENST00000272748.9 | NP_085153.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LNPK | ENST00000272748.9 | c.742A>G | p.Ile248Val | missense_variant | 10/13 | 1 | NM_030650.3 | ENSP00000272748.4 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 151962Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000585 AC: 146AN: 249722Hom.: 0 AF XY: 0.000711 AC XY: 96AN XY: 134996
GnomAD4 exome AF: 0.000411 AC: 598AN: 1454092Hom.: 0 Cov.: 27 AF XY: 0.000473 AC XY: 342AN XY: 723780
GnomAD4 genome AF: 0.000296 AC: 45AN: 152080Hom.: 0 Cov.: 31 AF XY: 0.000282 AC XY: 21AN XY: 74362
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.742A>G (p.I248V) alteration is located in exon 10 (coding exon 9) of the LNPK gene. This alteration results from a A to G substitution at nucleotide position 742, causing the isoleucine (I) at amino acid position 248 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | LNPK: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at